Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
InChiKey: XUKLGMSFWAEOPR-CMDGGOBGSA-N
is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway
1627676-59-8
PubMed PMID: 27815042
BMS-813160 - CAS# 1286279-29-5 184 InChiKey: XUKLGMSFWAEOPR-CMDGGOBGSA-NBMS 813160, CAS No. 1286279 29 5, is a potent and selective CCR2 CCR5 antagonist with potential immunomodulating and antineoplastic activities. BMS 813160 specifically binds and prevents the activation of both CCR2 and CCR5. This inhibits the activation of CCR2 CCR5 mediated signal transduction pathways and may inhibit inflammatory processes, angiogenesis, tumor cell migration, tumor cell proliferation and invasion. Product information CAS Number:
US$ 13.99
US$ 29.99
US$ 41.00
US$ 35.95